Perspectum Diagnostics Ltd   Report issue

For profit Phase 1
Founded: Oxford United Kingdom (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2017
NCT03261739
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Perspectum | Perspectum Diagnostics Ltd

Active Ingredients

Drugs in Phase 1 Trials (1)

ryi-018 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatty Liver (Phase 1)

Liver Diseases (Phase 1)

Non-alcoholic Fatty Liver Disease (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1